Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions

Author(s):  Wilder Alyson G, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A

Issue:  May/Jun 2020 - Volume 24, Number 3
View All Articles in Issue

Page(s):  238-241

Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions Page 1
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions Page 2
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions Page 3
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions Page 4

Download in electronic PDF format for $75

Abstract:  Using balanced fluids for resuscitation in patients with septic shock may lead to improved patient outcomes. However, compatibility data on co-administering balanced fluids via y-site connector with other intravenous medications is lacking. The purpose of this study was to examine the physical compatibility of frequently used intravenous medications for patients with septic shock with balanced fluids, Plasma-Lyte A, and Lactated Ringers, using a simulated y-site. Medications studied were acyclovir, amiodarone, ampicillin, aztreonam, cefepime, ceftriaxone, ciprofloxacin, heparin, hydrocortisone, gentamicin, levofloxacin, meropenem, piperacillin-tazobactam, tobramycin, and vancomycin. All medications were assessed with Plasma-Lyte A; amiodarone, ampicillin, cefepime, hydrocortisone, and levofloxacin were also assessed for compatibility with Lactated Ringers, based on missing or conflicting compatibility data. The medications were diluted to maximum concentrations used for patient administration and mixed with the balanced fluid solution in equal volumes. Physical compatibility was determined by assessing samples visually against light and dark backgrounds and using a laboratory turbidimeter. Assessments occurred at time of mixing and at 15-minute intervals up to one hour. Amiodarone demonstrated turbidimetric incompatibility when combined with Plasma- Lyte A or Lactated Ringers and should not be co-administered with either of these fluids via y-site connector. Each remaining study drug displayed visible and turbidimetric compatibility with the assessed balanced fluid. Acyclovir, ampicillin, aztreonam, cefepime, ceftriaxone, ciprofloxacin, gentamicin, heparin, hydrocortisone, levofloxacin, meropenem, piperacillin-tazobactam, tobramycin, and vancomycin exhibited physical compatibility with Plasma- Lyte A in a simulated y-site for up to one hour. Ampicillin, cefepime, hydrocortisone, and levofloxacin were also physically compatible with Lactated Ringers.

Related Keywords: critically ill patients, septic shock, sepsis, critical care, balanced fluid solutions, fluid resuscitation, intravenous fluid, Plasma-Lyte A, lactated Ringers, Y-site connector, concurrent administration, co-administration, co-infusion, physical compatibility, incompatibility, vasopressors, antibiotic, anti-infective agents, antimicrobial agents, acyclovir, amiodarone, ampicillin, aztreonam, cefepime, ceftriaxone, ciprofloxacin, heparin, hydrocortisone, gentamicin, levofloxacin, meropenem, piperacillin-tazobactam, tobramycin, vancomycin

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES, HEMOSTASIS, BLEEDING, ANTICOAGULATION

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions
Wilder Alyson G
, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A
May/Jun 2020
Pg. 238-241

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Technology Spotlight: Electronic Balances with Printer and Draft Shield
Wesolowski Paul
Mar/Apr 2003
Pg. 120-123

Chemical Stability of Amiodarone Hydrochloride in Intravenous Fluids
Pramar Yashoda V
Sep/Oct 1997
Pg. 347-348

Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration
Ben Michel
, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Sep/Oct 2008
Pg. 460-462

Hank's Balanced Salt Solution (Stock Solution)
Allen Loyd V Jr
Mar/Apr 2011
Pg. 160

Antique Pharmaceutical Balances
Richardson Charles G
Jul/Aug 1999
Pg. 280-283

Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride
Weeks Phillip A
, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
Mar/Apr 2014
Pg. 152-158

Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Foushee Jaime A
, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Jul/Aug 2016
Pg. 328-332

Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Maktabi Briana
, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
Nov/Dec 2022
Pg. 522-526

Quality Control Analytical Methods: Testing of Electrolytes Solutions
Vu Nicole
Jan/Feb 2009
Pg. 53-55

Stability of Magnesium Sulfate in 0.9% Sodium Chloride and Lactated Ringers Solutions
Sarver Jeffrey G
, Pryka Randy, Alexander Kenneth S, Weinstein Louis, Erhardt Paul W
Sep/Oct 1998
Pg. 385-388

Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Macklin Denise
, Blackburn Paul L
Mar/Apr 2013
Pg. 100-110

Patient-centered Care as Value-added Service by Compounding Pharmacists
McPherson Timothy B
, Fontane Patrick E, Day Jonathan R
Jul/Aug 2013
Pg. 339-343

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Ngim Kenley
, Patel Jalpa
May/Jun 2020
Pg. 242-245

Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin
, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M
Jan/Feb 2020
Pg. 64-68

Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care
Fassett William E
Nov/Dec 2003
Pg. 441-447

Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education
McElhiney Linda F
May/Jun 2009
Pg. 224-229

Home Infusion: Overview of the Infusion Patient-Care Process
Kennedy Steve
Jul/Aug 2011
Pg. 270-276

Return to Top